Skin News and Research

RSS

Vitamin D deficient rickets in infants

The message about preventing vitamin D deficient rickets in children is not getting through, warn senior doctors in this week's BMJ.

23 Jun 2007

Neurological reason for doing mindfulness meditation

Talking with a therapist or friend, writing in a journal, help us to feel better! A new brain imaging study by UCLA psychologists reveals why verbalizing our feelings makes our sadness, anger and pain less intense.

23 Jun 2007

New compound kills fungal pathogens

A new mechanism to attack hard-to-treat fungal infections has been revealed by scientists from the biotech company Anacor Pharmaceuticals Inc., California, and the European Molecular Biology Laboratory (EMBL) outstation in Grenoble, France.

23 Jun 2007

Arpida receives FDA approval to initiate Phase II trial with intravenous iclaprim

Arpida Ltd. has announced that it has received approval from the US Food and Drug Administration for a Phase II trial with intravenous iclaprim in the treatment of patients with hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP) or healthcare-associated pneumonia (HCAP) suspected or confirmed to be due to Gram-positive pathogens.

23 Jun 2007

Review of the routine monitoring of growth in children of primary school age to identify growth-related conditions

No sound evidence supports weight monitoring to identify and treat obese children, according to a review of worldwide research published this month in the United Kingdom.

23 Jun 2007

Thermage sues Alma Lasers for patent infringement

Thermage, Inc. has announced that it has filed a patent infringement lawsuit against Alma Lasers, Ltd. and Alma Lasers, Inc. in Delaware Federal District Court.

23 Jun 2007

Discomfort and disability caused by shingles can be avoided

The painful, burning twinge and irritate skin that can be an early warning sign of shingles is often overlooked or misdiagnosed at the time when antiviral medications can be effected at shortening the outbreak.

23 Jun 2007

Goltz syndrome gene found

Researchers funded in part by the National Institutes of Health have identified the gene that accounts for most cases of Goltz syndrome, a rare skin disorder that can also affect bone and eye development.

23 Jun 2007

FDA approves Differin (adapalene) gel, 0.3% for acne

Galderma Laboratories, L.P., has announced that the U.S. Food and Drug Administration (FDA) has approved Differin (adapalene) Gel, 0.3%, a new, higher concentration formulation of Differin (adapalene) 0.1%, a topical retinoid indicated for the treatment of acne.

23 Jun 2007

New way to increase stem cells in blood

Researchers at Children's Hospital Boston report finding a new way to increase stem cells in blood, suggesting a possible treatment to help patients who undergo chemotherapy or bone marrow transplant for leukemia and other cancers recover their immune function more quickly.

23 Jun 2007

Men bitten more often than women and alcohol is the culprit

A new study by doctors in Ireland has found that men are 12 times more likely than women to be bitten by another person and need surgery.

21 Jun 2007

Why the cold hurts - research has implications for pain relief

Freeing knotted shoelaces with fingers that are frozen stiff is extremely difficult and can even be painful.

20 Jun 2007

Men are 12 times more likely than women to sustain severe human bite injuries

The researchers reviewed the 92 patients requiring assessment for human bite wounds by the plastic surgery service at St James Hospital Dublin, Ireland, between January 2003 and December 2005. Eight five of them (92%) were men and the 92 patients had a total of 96 bites.

20 Jun 2007

Intraoperative radiation therapy for breast cancer

Princess Margaret Hospital (PMH) breast cancer specialists are using a new way to treat patients by delivering a one-time dose of radiation during surgery.

20 Jun 2007

New database tells which sunscreens are safe and effective

According to a nonprofit research organization in the United States not all sunscreens offer adequate protection from the sun's harmful rays and some can in fact harm the skin.

20 Jun 2007

Extended exposure to the psoriasis medication etanercept reduces psoriasis severity without increased adverse events

Extended exposure to the psoriasis medication etanercept does not appear to cause more infections or adverse events than placebo, and improvements in several measures of disease severity were observed for up to 96 weeks of therapy, according to a study in the June issue of Archives of Dermatology.

19 Jun 2007